At every #NephJC chat I find myself delighted with the bits of Twitter wisdom that get funneled through the hashtag. We are going to try to do a better job of rewarding the best of these. Some of these awards will even have prizes. This week we are delighted to announce winners of a great looking JAMA coffee mug, named the JAMAcup in this pre-chat banter:

The things I do to win the JAMA cup. Up tweeting even before my morning coffee. Interesting topic #nephjc #TooEarly #India
— Sanjeev Nair (@Nair_Sanj) August 12, 2015

Can we hashtag #JAMAcup? #nephjc
— Joel Topf (@kidney_boy) August 12, 2015

The winner of the #JAMAcup for the Tuesday night chat is Azra Bihorac (@AzraBihorac) who wrote this gem:

#nephjc yet all we talk about ad nausea is preop cardiac eval YET POSTOP MI is rare and POSTOP AKI IS one of the most common complication
— Azra Bihorac (@AzraBihorac) August 12, 2015

We would also like to give honorable mention (but no mug) to Mike Walsh (@lastwalsh) who was the first to alert us to the negative results for RIPC in other large trials:

T3: @NephJC problem is RIPHEART and ERRICA both negative as were the Korean trials. This trial looks like a chance finding #nephjc
— mike walsh (@lastwalsh) August 12, 2015

The Wednesday chat was great and picking a winner was difficult but we selected this dejavu all over again tweet by Graham Abra (@GrahamAbra):

T3: Don't want N-acetylcysteine all over again... Low risk intervention might save world.. Data muddy for next 20 years... #NephJC
— Graham Abra, MD (@GrahamAbra) August 12, 2015

Honorable mention to Michael Hultström (@mhulstrom) for this:

@kidney_boy Does sleeping on your arm protect you from heart attacks and AKI? #nephjc
— Michael Hultström (@mhultstrom) August 12, 2015

A hearty thanks to JAMA. We love working with them and appreciate their support of post-publication peer review.